Behind the Numbers: Digital Health Trends for 2025—DTC Drugs and Rising Health Costs

Podcast: Behind the Numbers: an EMARKETER Podcast
Host: Marcus
Guests: Rajiv Leventhal (Senior Digital Health Analyst, New Jersey) and Dane Finley (Senior Digital Health Analyst, Virginia)
Release Date: January 27, 2025

In the January 27, 2025 episode of Behind the Numbers, host Marcus engages in a compelling discussion with senior digital health analysts Rajiv Leventhal and Dane Finley. The episode delves into two significant trends shaping the digital health landscape for 2025: the rise of Direct-to-Consumer (DTC) healthcare and pharmaceutical services, and the impact of escalating health costs on consumer behavior.

1. The Rise of Direct-to-Consumer Healthcare and Pharmaceuticals

Rajiv Leventhal kicks off the conversation by highlighting a pivotal shift in the healthcare and pharmaceutical industries. Traditionally, these sectors have relied heavily on intermediaries such as health insurers and pharmacy benefit managers (PBMs) to reach consumers. However, Rajiv notes a transformative movement towards DTC models, allowing companies to establish direct relationships with patients.

Rajiv Leventhal [03:57]: “More companies in healthcare and pharma will move into the direct-to-consumer market, cutting out middlemen to reach patients directly and generate revenue through alternative sales channels.”

**Examples of this trend are evident with giants like Eli Lilly and Pfizer, who have launched DTC websites enabling consumers to consult with affiliated telehealth providers and access prescription medications directly. Rajiv explains how this streamlined process allows patients to receive medications without the traditional friction points associated with insurance and PBM involvement.

Rajiv Leventhal [05:10]: “You can go on these pharmaceutical company websites, talk to a telehealth provider affiliated with them, and receive your medication shipped to your home within a day or two.”

Dane Finley adds to the discussion by addressing the ethical and regulatory challenges accompanying this shift. He points out that the direct connection between pharmaceutical companies and consumers raises potential conflicts of interest, especially when telehealth providers may be incentivized to prescribe specific drugs.

Dane Finley [17:17]: “There are legitimate concerns around the agreements between drug makers and doctors, questioning whether prescriptions are always in the best interest of the patient.”

The analysts also discuss the impact of legislative changes, such as the Inflation Reduction Act, which imposes price controls on drugs for Medicare patients, prompting pharmaceutical companies to explore DTC channels as a means to maintain profitability amidst tighter regulations.

2. Rising Healthcare Costs and Increasing Consumer Price Consciousness

Shifting focus, Dane Finley introduces the second major trend: rising healthcare costs are driving consumers to become more price-conscious. This behavior is particularly pronounced among younger generations, including Gen Z and millennials, who are more inclined to shop around for the best deals on medications, insurance plans, and medical services.

Dane Finley [10:02]: “With healthcare costs expected to rise by another 8% in 2025, consumers are increasingly compelled to compare prices for medications and services to manage their out-of-pocket expenses.”

Rajiv Leventhal elaborates on this trend by explaining that unlike purchasing consumer electronics or groceries, healthcare decisions have historically been controlled by insurance companies and healthcare providers. However, as patients bear more of the cost burden, they are gaining greater autonomy and are now more engaged in making informed healthcare choices.

Rajiv Leventhal [11:10]: “For the first time, patients are more likely to compare prices and quality for medications and treatments because they’re directly responsible for a larger share of the costs.”

The conversation also touches on the proliferation of subscription-based models and DIY health solutions. Companies like Hers and Ro are highlighted as examples of businesses offering prescription medications through subscription services, bypassing traditional insurance constraints and providing more affordable options to consumers.

Dane Finley [22:01]: “We’re seeing more subscription models where consumers can bypass insurance and access medications at lower costs, which is a direct response to the rising expenses and the need for more control over their healthcare spending.”

Furthermore, the analysts discuss the anticipated growth in over-the-counter supplements, wearable health devices, and at-home medical testing kits as consumers seek more convenient and cost-effective ways to monitor and manage their health.

3. Ethical Considerations and Regulatory Scrutiny

The episode doesn't shy away from the ethical dilemmas posed by these trends. Rajiv Leventhal raises concerns about the potential for conflicts of interest when pharmaceutical companies directly influence patient prescriptions through affiliated telehealth providers.

Rajiv Leventhal [18:27]: “It seems crazy that a consumer can request a specific medication they saw advertised and have it prescribed through a company-affiliated doctor, which blurs the line between patient care and corporate interests.”

Dane Finley concurs, emphasizing the need for stringent regulatory oversight to ensure that patient welfare remains the priority over corporate profits.

Dane Finley [25:03]: “There’s a critical question of whether every patient receiving a drug through these DTC channels truly needs it, highlighting the importance of ethical practices in this evolving landscape.”

Conclusion: Navigating the Future of Digital Health

As the discussion wraps up, Marcus commends both analysts for their insightful contributions, awarding them as "Star Bakers" for their exceptional analysis of overlapping trends. He encourages listeners to explore further details in eMarketer’s comprehensive reports available to Pro subscribers.

Marcus [26:49]: “Thank you, Rajiv and Dane, for shedding light on these transformative trends. Your insights are invaluable as we navigate the future of digital health.”

The episode closes with a brief mention of upcoming content, including a new series on Retailer Rankings, ensuring listeners are kept engaged and informed on the latest developments in digital media and marketing.

Key Takeaways:

• DTC Healthcare Growth: Pharmaceutical and healthcare companies are increasingly adopting DTC models to reach consumers directly, bypassing traditional intermediaries and providing more streamlined access to medications and services.

• Consumer Price Sensitivity: Rising healthcare costs are driving a significant portion of the population, especially younger generations, to become more price-conscious, leading to increased price comparison and the adoption of alternative purchasing models.

• Ethical and Regulatory Challenges: The convergence of corporate interests and patient care in DTC channels raises important ethical questions and necessitates robust regulatory frameworks to protect consumer interests.

By exploring these trends, the episode provides a comprehensive overview of the dynamic shifts in the digital health sector, offering valuable insights for marketers, retailers, and healthcare professionals aiming to stay ahead in an ever-evolving landscape.